Malignant tumor overview.
Reardon MJ.
Methodist Debakey Cardiovasc J. 2010 Jul-Sep;6(3):35-7. doi: 10.14797/mdcj-6-3-35.
Oncolytic Virotherapy for Malignant Tumor: Current Clinical Status.
Zhang Y, Liu Z.
Curr Pharm Des. 2019;25(40):4251-4263. doi: 10.2174/1381612825666191104090544.
Malignant trichilemmal carcinoma misdiagnosed with parotid gland malignant tumor.
Terenzi V, Martellucci S, Dal Cortivo F, Stolfa A, Fiorentino F, Clemenzi V, Gallo A, Valentini V, Pagliuca G.
Oral Oncol. 2023 Feb;137:106303. doi: 10.1016/j.oraloncology.2022.106303. Epub 2023 Jan 2.
Multivariate saturation treatment of malignant tumor.
Liu R, Liu Q.
Asian J Surg. 2021 Jan;44(1):1. doi: 10.1016/j.asjsur.2020.10.023. Epub 2020 Nov 18.
Tumor Macroenvironment: An Update.
Al-Zoughbi W, Hoefler G.
Pathobiology. 2020;87(2):58-60. doi: 10.1159/000502097. Epub 2019 Sep 4.
Malignant peripheral nerve sheath tumor of tongue: a case report.
Liu Y, Wu D, Lun X, Dai W.
Hua Xi Kou Qiang Yi Xue Za Zhi. 2023 Jun 1;41(3):361-364. doi: 10.7518/hxkq.2023.2022402.
The role of RhoC in malignant tumor invasion, metastasis and targeted therapy.
Guan X, Chen S, Zhao Y.
Histol Histopathol. 2018 Mar;33(3):255-260. doi: 10.14670/HH-11-915. Epub 2017 Jun 30.
Correlation between lymphoma and second primary malignant tumor.
Liu L, Zhang Q, Chen B.
Medicine (Baltimore). 2023 May 12;102(19):e33712. doi: 10.1097/MD.0000000000033712.
Circular RNA circSMARCA5 is a prognostic biomarker in patients with malignant tumor: a meta-analysis.
Chao F, Wang S, Zhang C, Han D, Ma Z, Chen G.
BMC Cancer. 2021 May 25;21(1):600. doi: 10.1186/s12885-021-08316-3.
Neonatal oncology.
Bertolone S.
Pediatr Clin North Am. 1977 Aug;24(3):585-98. doi: 10.1016/s0031-3955(16)33467-8.
